Live Bending Spoons Vote →

Never Miss Important Company Updates Again

Get AI-powered summaries of SEC filings delivered to your inbox

Follow your favorite stocks and get email alerts when they release important updates. Completely free.

Covers 5,000+ public companies
Get started →
Sign up to stay up to date with the stocks you care about

Liminatus Pharma, Inc.

LIMN LIMNW

Latest SEC Filings from Liminatus Pharma, Inc.

  1. 1
    1

    Liminatus Pharma Reports $2.53 Million Net Loss and Significant Asset Growth in Latest 10-Q

    via official filing (AI summary) 2 months ago 0 comments
  2. 2
    1

    Liminatus Pharma Reports Increased Losses and Improved Liquidity in Latest 10-Q Filing

    via official filing (AI summary) 5 months ago 0 comments
  3. 3
    1

    Liminatus Pharma Reports $10.2 Million Net Loss for Fiscal Year 2025

    via official filing (AI summary) 7 months ago 0 comments
  4. 4
    1

    Liminatus Pharma Reports Improved Net Loss and Significant Business Changes in Latest 10-Q

    via official filing (AI summary) 11 months ago 0 comments
  5. 5
    1

    Liminatus Pharma Reports Net Income of $113,287 in Q2 2025, Significant Improvement from Prior Year

    via official filing (AI summary) about 1 year ago 0 comments
  6. 6
    1

    Liminatus Pharma Reports Increased Net Loss and Financial Deficit Following Business Combination

    via official filing (AI summary) over 1 year ago 0 comments